助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[44]条 当前为第1条到20条
 

相关语句
tumor patient
    sIL-2R Level Assay in Peripheral Blood of the Tumor Patient Before and After Treatment
    肿瘤患者治疗前后外周血sIL-2R水平测定
    Preliminary study on the ascorbic acid level of tumor patient
    肿瘤患者抗坏血酸水平的初步研究
    Preliminary Observation of the in vitro Antitumor Effects of CD 3AK Cells Induced from Tumor Patient′s PBMC
    肿瘤患者外周血单个核细胞诱导的CD_3AK细胞体外抗肿瘤作用的初步观察
    Analysis of antibody examination of the tumor patient combined gondii infection
    肿瘤患者合并弓形虫感染血清抗体检测分析
    The effect of immune function for tumor patient with NDV-ATV treatment after operation
    NDV-ATV对肿瘤患者术后免疫功能的影响
    THE APPLICATION OF DOT IMMUNOGOLD FILTRATION ASSAY FOR THE DETECTION OF ANTIBODY TOXOPLASMA GONDII IgG IN SERUM OF THE TUMOR PATIENT
    斑点金免疫渗滤法检测肿瘤患者血清弓形虫IgG抗体的应用研究
    A new mutation in the KIT ATP pocket causes acquired resistance to imati nib in a gastrointestinal stromal tumor patient
    KIT ATP袋结构域的一个新突变导致胃肠间质肿瘤患者对伊马替尼获得性耐药
    Effect of Social and Mental Factors on the Quality of Life of Tumor Patient
    社会心理因素对肿瘤患者生存质量的影响
    In addition, ELISA, Dot blot and Western blot were used to compare the antibody levels in normal and tumor patient's serum.
    采用ELISA、Dotblot、Westernblot法比较正常人及肿瘤患者血清中抗体水平的差异。
    the NK activity (killing K562 cell) of malignant tumor patient's PBMC had grown up to 82% from 62% by CD 3AK cell transfusing, the even rising ratio is 32%.
    肿瘤患者输注CD3 AK细胞一疗程后 ,其PBMC的NK杀伤活性由 6 2 %升高到 82 % ,平均升高 32 %。
    (3) The NK activity of malignant tumor patient's PBMC can be obviously elevated by transfusing CD 3AK cell.
    (3)CD3 AK细胞输注能明显提高肿瘤患者PBMC的NK活性。
    3) The T cells subgroup absolute count and the NK activity of malignant tumor patient's PBMC can be obviously elevated by transfusing CD3AK cell.
    3)CD3AK细胞输注能明显提高肿瘤患者外周血T淋巴细胞亚群绝对计数和PBMC的NK活性。
    ELISA results showed OD mean's of normal serum group was 0.20±0.05, and tumor patient's serum group was 0.36±0.12, the difference was significant, positive rate was 40%(46/116) of tumor serum.
    ELISA检测显示,正常人和肿瘤患者血清抗体水平存在显著性差异(P <0 .0 0 1)。 正常人组OD均值为0 . 2 0±0 0 5 ,肿瘤患者组OD均值为0 . 36±0. 12 ,肿瘤患者中阳性率为4 0 % (46 / 116 )。
    Results The NK activity (killing K562 cell) of malignant tumor patient′s PBMC had grown up to 81% from 63% by CD_3AK cell transfusing,the even rising ratio is 28%. The fever cases is less than 3%,major was under 38 ℃,and was returned to normal in 2 h without special treatment.
    结果肿瘤患者输注CD3AK细胞一个疗程后,其PBMC的NK杀伤活性由63%升高到81%,平均升高28%,发热反应不到3%,大多在38℃以下,未经处理自行消退。
    Conclusion (1) The NK activity of malignant tumor patient′s PBMC can be obviously elevated by transfusing CD_3AK cell.
    结论(1)CD3AK细胞输注能明显提高肿瘤患者PBMC的NK活性;
    (3) The test of NK activity of PBMC of malignant tumor patient may become a recent objective immune index for tumor bio-therapy.
    (3)肿瘤患者PBMC的NK活性测定可望成为肿瘤生物治疗近期疗效的一个参数。
    Conclusion The terminal Galbeta1-4GlcNAc related polysac- haride in serum can be applied to the research of abnormal polysaccharide in tumor patient and pathogenesis. Its level can provide reference for clinical diagnosis and the evaluation on curative effect.
    结论血清中RCAⅠ相关的末端Galβ1-4GlcNAc多糖分子,可用于肿瘤患者血清糖基化异常和肿瘤发病机制的研究,并可为临床诊断和治疗效果的评价提供参考指标。
    THE EFFECT OF POLYACTIN A ON THE LYMPHOCYTE IMMUNOFUNCTION OF THE TUMOR PATIENT
    多抗甲素对肿瘤患者淋巴细胞免疫功能影响
    Psychosomatic Change and Recuperate under Medical Treatment of Tumor Patient
    肿瘤患者心态变化及其心理调治
    Research of N and H Content in Tumor Patient Using In Vivo N A A
    运用活体中子活化分析法研究肿瘤患者体内氮氢元素
 

首页上一页123下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社